找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Melanoma; Howard L. Kaufman,Janice M. Mehnert Book 2016 Springer International Publishing Switzerland 2016 Diagnosis.Immunotherapy.Melanom

[复制链接]
楼主: Hayes
发表于 2025-3-28 17:21:16 | 显示全部楼层
发表于 2025-3-28 19:02:57 | 显示全部楼层
发表于 2025-3-29 02:21:36 | 显示全部楼层
Melanoma Epidemiology and Prevention,well. Sun exposure can be classified as intermittent, chronic, or cumulative (overall) exposure, and each appears to have a different effect on type of melanoma. Other environmental factors, such as chemical exposures—either through occupation, atmosphere, or food—may increase risk for melanoma, and
发表于 2025-3-29 05:17:18 | 显示全部楼层
发表于 2025-3-29 08:39:40 | 显示全部楼层
Melanoma: Clinical Presentations,on the skin. However, melanoma can also arise on mucosal surfaces such as the oral cavity, the upper gastrointestinal mucosa, the genital mucosa, as well as the uveal tract of the eye and leptomeninges. Melanomas tend to be pigmented but can also present as pink or red lesions. They can mimic benign
发表于 2025-3-29 14:10:36 | 显示全部楼层
Principles of Melanoma Staging,system is a relatively modern concept. Overall, the goals of cancer staging are to characterize the status of cancer at a specific moment in time, risk stratify, facilitate prognostication, and inform clinical decision making. The revisions to the American Joint Committee on Cancer (AJCC) melanoma s
发表于 2025-3-29 16:12:45 | 显示全部楼层
发表于 2025-3-29 23:25:29 | 显示全部楼层
Adjuvant Therapy of Melanoma, melanoma tumorigenesis have established roles for inhibitors of the MAPK pathway and regulatory immune checkpoints CTLA-4 and PD-1/PD-L1. However, the majority of patients continue to present with non-metastatic disease—typically managed with surgical resection and adjuvant therapy. High-dose IFN-α
发表于 2025-3-30 00:20:48 | 显示全部楼层
发表于 2025-3-30 05:58:18 | 显示全部楼层
Checkpoint Blockade for the Treatment of Advanced Melanoma,nt inhibition has been most extensively studied in patients with advanced melanoma and there are three FDA approved antibodies already widely used in clinical practice (ipilimumab, nivolumab, and pembrolizumab). In this chapter, we review the mechanistic basis behind the development of immune checkp
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-17 11:51
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表